TESTOSTERONE THERAPY AND SUBCLINICAL ATHEROSCLEROSIS PROGRESSION AMONG MEN WITH HIV
Testosterone therapy (TTh) use is highly prevalent among middle-aged and older men with HIV (MWH) in the United States, but its cardiovascular safety is unclear. We assessed progression of subclinical coronary artery disease by TTh use status among MWH in the Multicenter AIDS Cohort Study (MACS). MWH in the MACS CVD sub-study in 4 U.S. cities…